Rearrangements involving the KMT2A gene, formerly known as mixed-lineage leukemia (MLL), represent some of the most frequent chromosomal alterations found in both AML and ALL, encompassing a wide range of fusion partners. The gene discussed is KMT2A; the disease is acute myeloid leukemia.